Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07005362 · ClinicalTrials.gov registry record
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
A clinical trial of Type 2 Diabetes and Type 2 Diabetes Mellitus (T2DM), sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT07005362 is a study of Type 2 Diabetes and Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 36 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07005362, a study of Type 2 Diabetes and Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management education and support (DSMES) with tailored text messages. The main question it aims to answer is: Does providing a wearable fitness and activity tracker plus AI-tailored and DSMES improve clinical outcomes for patients with type 2 diabetes? Participants will complete a baseline visit, wear a Fitbit and answer text messages for 12-weeks, and complete by a final visit.
Conditions Studied
Interventions
- BEHAVIORAL Fitbit and AI Chatbot
- OTHER Routine Care
Study Locations (1)
Colorado
- University of Colorado, Anschutz - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-09-03 |
| Est. Completion | 2026-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07005362
The ClinicalTrials.gov registry entry for NCT07005362 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Fitbit and AI Chatbot is the first listed.
NCT07005362 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT07005362 about?
NCT07005362 is a clinical study titled "Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D". The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management education and support (DSMES) with tailored text messages. The main question it aims to answer is: ...
What is the current status of trial NCT07005362?
This trial is currently recruiting. The enrollment target is 36 participants. The study started on 2025-09-03. Estimated completion is 2026-04-30.
What conditions does trial NCT07005362 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), T2DM (Type 2 Diabetes Mellitus), T2D, Remote Patient Monitoring.
What interventions are being tested in trial NCT07005362?
The interventions under investigation include: Fitbit and AI Chatbot (BEHAVIORAL), Routine Care (OTHER).
Who is sponsoring clinical trial NCT07005362?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07005362 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.